Search
SOLACI Congress
HomeFile

File

View Category
HIGHLIGHTS

Less than 20% of patients that could benefit from TAVR are receiving it

 The introduction of transcatheter aortic valve replacement procedures (TAVR) seems to have increased the number of elderly...
solaci -
Learn More
Chronic Ischemic cardiopathy

Non-Cardiac Surgery with Incomplete Revascularization, Associated to Events

This study presented at the American Heart Association Scientific Sessions 2016 and simultaneously published in the Journal of...
solaci -
Learn More
Chronic Ischemic cardiopathy

Women: More Prone to Lower Coronary Flow Reserve

Compared to men, women have less chances of developing obstructive coronary artery disease (CAD), but this new...
solaci -
Learn More
Acute coronary syndromes

Contemporary Ventricular Assist Devices: Hemodynamic Consequences

Courtesy of Dr. Agustín Vecchia. Despite current technological advancements and improvement in reperfusion rates in a setting of infarction, cardiogenic...
solaci -
Learn More
Structural heart disease

TAVR: The Need for a Pacemaker Is Associated with Mortality

Courtesy of Dr. Carlos Fava.   After a transcatheter aortic valve replacement (TAVR), the incidence of permanent pacemaker (PPM) implantation...
solaci -
Learn More
Bifurcations

Bifurcation Lesion in Distal Left Main Coronary Artery: One or Two Stents?

Courtesy of Dr. Carlos Fava. Unprotected left main coronary artery (LMCA) angioplasty has become an important trend in the...
solaci -
Learn More
Structural heart disease

Post-TAVI Definite Pacemaker: How Harmless Is It?

Courtesy of Dr. Carlos Fava.   Transcatheter aortic valve replacement (TAVR) has shown ample benefit in different groups, but...
solaci -
Learn More
Structural heart disease

Valve Thrombosis After TAVR: Larger-Diameter Valves and No Warfarin as Predictors

There are limited data on the incidence, clinical implications, and predisposing factors of valve thrombosis in patients...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Dr. Omar Tupayachi - 0
Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Dr. Juan Manuel Pérez - 0
Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....

TAVR in Pure Native Aortic Regurgitation: Are Dedicated Devices Truly Superior?

Dr. Juan Manuel Pérez - 0
This systematic meta-analysis assessed the efficacy and safety of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation. The emergence of...

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy